Terms: = Skin cancer AND SSX4, MGC119056, 6759, ENSG00000204645, O60224, MGC12411
10 results:
1. Global microRNA profiling of metastatic conjunctival melanoma.
Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S
Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942
[TBL] [Abstract] [Full Text] [Related]
2. Correlation Between Expression of the cancer/Testis Antigen KK-LC-1 and
Fukuyama T; Futawatari N; Ichiki Y; Shida A; Yamazaki T; Nishi Y; Nonoguchi H; Takahashi Y; Yamazaki H; Kobayashi N
In Vivo; 2017; 31(3):403-407. PubMed ID: 28438869
[TBL] [Abstract] [Full Text] [Related]
3. The "melanoma-enriched" microRNA miR-4731-5p acts as a tumour suppressor.
Stark MS; Tom LN; Boyle GM; Bonazzi VF; Soyer HP; Herington AC; Pollock PM; Hayward NK
Oncotarget; 2016 Aug; 7(31):49677-49687. PubMed ID: 27331623
[TBL] [Abstract] [Full Text] [Related]
4. Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade.
Lotem M; Merims S; Frank S; Hamburger T; Nissan A; Kadouri L; Cohen J; Straussman R; Eisenberg G; Frankenburg S; Carmon E; Alaiyan B; Shneibaum S; Ozge Ayyildiz Z; Isbilen M; Mert Senses K; Ron I; Steinberg H; Smith Y; Shiloni E; Gure AO; Peretz T
J Immunol Res; 2016; 2016():8121985. PubMed ID: 27294163
[TBL] [Abstract] [Full Text] [Related]
5. Meta-analysis of the Correlation Between Interleukin-6 Promoter Polymorphism -174G/C and Interferon Regulatory Factor 4 rs12203592 Polymorphism With skin cancer Susceptibility.
Wu M; Cao Y; Liu YL; Ma LL; Yang XH
Am J Ther; 2016; 23(6):e1758-e1767. PubMed ID: 26928068
[TBL] [Abstract] [Full Text] [Related]
6. Effects of CT-Xp gene knock down in melanoma cell lines.
Caballero OL; Cohen T; Gurung S; Chua R; Lee P; Chen YT; Jat P; Simpson AJ
Oncotarget; 2013 Apr; 4(4):531-41. PubMed ID: 23625514
[TBL] [Abstract] [Full Text] [Related]
7. EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors.
Neumann F; Kaddu-Mulindwa D; Widmann T; Preuss KD; Held G; Zwick C; Roemer K; Pfreundschuh M; Kubuschok B
Cancer Immunol Immunother; 2013 Jul; 62(7):1211-22. PubMed ID: 23619976
[TBL] [Abstract] [Full Text] [Related]
8. CD4+ T cell responses to SSX-4 in melanoma patients.
Ayyoub M; Merlo A; Hesdorffer CS; Rimoldi D; Speiser D; Cerottini JC; Chen YT; Old LJ; Stevanovic S; Valmori D
J Immunol; 2005 Apr; 174(8):5092-9. PubMed ID: 15814740
[TBL] [Abstract] [Full Text] [Related]
9. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.
dos Santos NR; Torensma R; de Vries TJ; Schreurs MW; de Bruijn DR; Kater-Baats E; Ruiter DJ; Adema GJ; van Muijen GN; van Kessel AG
Cancer Res; 2000 Mar; 60(6):1654-62. PubMed ID: 10749136
[TBL] [Abstract] [Full Text] [Related]
10. SSX: a multigene family with several members transcribed in normal testis and human cancer.
Gure AO; Türeci O; Sahin U; Tsang S; Scanlan MJ; Jäger E; Knuth A; Pfreundschuh M; Old LJ; Chen YT
Int J Cancer; 1997 Sep; 72(6):965-71. PubMed ID: 9378559
[TBL] [Abstract] [Full Text] [Related]
